Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. (Q53469087)
Jump to navigation
Jump to search
scientific article published on 10 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. |
scientific article published on 10 August 2007 |
Statements
Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. (English)
1 reference
1 reference
Masaru Taniguchi
1 reference
Tetsuro Uchida
1 reference
Shigetoshi Horiguchi
1 reference
Yuriko Tanaka
1 reference
Heizaburo Yamamoto
1 reference
Naoki Kunii
1 reference
Shinichiro Motohashi
1 reference
Yoshitaka Okamoto
1 reference
10 August 2007
1 reference
57
1 reference
337-345
1 reference
3
1 reference
Identifiers
1 reference